股本结构
单位：万股
| 公告日期 | 2026-09-29 | 2026-08-27 | 2026-08-12 | 2026-09-30 | 2026-08-12 | 2026-06-29 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2638.41 | 2175.48 | 2057.86 | 2056.50 | 1520.32 | 1520.32 |
| 普通股本 | 2638.41 | 2175.48 | 2057.86 | 2056.50 | 1520.32 | 1520.32 |
| 优先股 | 未披露 | 未披露 | 未披露 | 245.26 | 245.26 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-09-28 | 2026-08-25 | 2026-08-10 | 2026-08-07 | 2026-06-30 | 2026-06-26 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-09-29 | 2638.41 | 未披露 | 定期报告 | 2026-09-28 |
| 2026-08-27 | 2175.48 | 未披露 | 定期报告 | 2026-08-25 |
| 2026-08-12 | 2057.86 | 未披露 | 定期报告 | 2026-08-10 |
| 2026-09-30 | 2056.50 | 245.26 | 定期报告 | 2026-08-07 |
| 2026-08-12 | 1520.32 | 245.26 |
更多>>
From March 31,2026 to June 30,2026
Issuance of common stock pursuant to equity line of credit, net of fees
Issuance of common stock pursuant to Senior Convertible Notes
|
2026-06-30 |
| 2026-06-29 | 1520.32 | 未披露 | 定期报告 | 2026-06-26 |
| 2026-05-20 | 1262.59 | 未披露 | 定期报告 | 2026-05-19 |
| 2026-05-07 | 1443.59 | 245.26 | 定期报告 | 2026-04-22 |
| 2026-04-16 | 1145.37 | 未披露 | 定期报告 | 2026-03-31 |
| 2026-02-12 | 908.79 | 245.26 | 定期报告 | 2026-01-29 |
| 2026-04-16 | 877.29 | 245.24 |
更多>>
From January 1,2025 to December 31,2025
Net public offering proceeds
Conversion of Class B Preferred Units to Common stock
Issuance of common stock pursuant to Senior Convertible Note
Issuance of commitment shares pursuant to equity line of credit
Issuance of common stock pursuant to equity line of credit
Nectarine Management, LLC. Subscription Agreement
|
2025-12-31 |
| 2025-11-18 | 830.62 | 未披露 | 定期报告 | 2025-11-14 |
| 2025-10-23 | 790.62 | 未披露 | 定期报告 | 2025-10-22 |
| 2025-11-18 | 630.62 | 245.26 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock pursuant to equity line of credit
Issuance of common stock pursuant to Senior Convertible Note
Conversion of note payable to Brookstone to Series Z Preferred Stock
Conversion of note payable to BP Peptides, LLC to Series Z Preferred Stock
|
2025-09-30 |
| 2025-10-01 | 630.62 | 98.51 | 定期报告 | 2025-09-24 |
| 2025-08-15 | 558.12 | 未披露 | 定期报告 | 2025-08-12 |
| 2025-09-04 | 546.87 | 98.51 | 定期报告 | 2025-07-09 |
| 2025-08-15 | 540.63 | 98.51 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of commitment shares pursuant to equity line of credit
Issuance of common stock pursuant to equity line of credit
|
2025-06-30 |
| 2025-03-07 | 519.03 | 未披露 | 定期报告 | 2025-03-06 |
| 2009-03-13 | 4077.54 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Compensation earned on stock awards
Common stock purchased and retired
|
2008-12-31 |
| 2008-03-05 | 4175.81 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Compensation earned on stock awards
|
2007-12-31 |
| 2007-03-14 | 4159.45 | 未披露 | 定期报告 | 2007-02-28 |
| 2007-03-14 | 4156.43 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Exercise of common stock options
Sales of common stock
Compensation earned on restricted stock
Acquisition of AzERx
|
2006-12-31 |
| 2006-03-13 | 4034.61 | 未披露 | 定期报告 | 2006-02-27 |
| 2006-03-13 | 3812.47 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Exercise of common stock options
|
2005-12-31 |
| 2005-02-28 | 3801.16 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Exercise of common stock options
Acquisition of CBI
|
2004-12-31 |
| 2004-03-15 | 3451.76 | 未披露 | 定期报告 | 2004-03-08 |
| 2004-03-15 | 3353.34 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Exercise of common stock options
Common stock issued in connection with legal settlement
|
2003-12-31 |
| 2003-03-28 | 3287.36 | 未披露 | 定期报告 | 2003-03-12 |
From March 31,2026 to June 30,2026
Issuance of common stock pursuant to equity line of credit, net of fees
Issuance of common stock pursuant to Senior Convertible Notes
From January 1,2025 to December 31,2025
Net public offering proceeds
Conversion of Class B Preferred Units to Common stock
Issuance of common stock pursuant to Senior Convertible Note
Issuance of commitment shares pursuant to equity line of credit
Issuance of common stock pursuant to equity line of credit
Nectarine Management, LLC. Subscription Agreement
From June 30, 2025 to September 30, 2025
Issuance of common stock pursuant to equity line of credit
Issuance of common stock pursuant to Senior Convertible Note
Conversion of note payable to Brookstone to Series Z Preferred Stock
Conversion of note payable to BP Peptides, LLC to Series Z Preferred Stock
From March 31, 2025 to June 30, 2025
Issuance of commitment shares pursuant to equity line of credit
Issuance of common stock pursuant to equity line of credit
from December 31, 2007 to December 31, 2008
Compensation earned on stock awards
Common stock purchased and retired
from December 31, 2006 to December 31, 2007
Compensation earned on stock awards
from December 31, 2005 to December 31, 2006
Exercise of common stock options
Sales of common stock
Compensation earned on restricted stock
Acquisition of AzERx
from December 31, 2004 to December 31, 2005
Exercise of common stock options
from December 31, 2003 to December 31, 2004
Exercise of common stock options
Acquisition of CBI
from December 31, 2002 to December 31, 2003
Exercise of common stock options
Common stock issued in connection with legal settlement